trial · primary record
OPB-201
Endometrial Cancer Recurrent
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2030-09 |
| Primary endpoint | Incidence of all treatment-emergent adverse events (TEAEs); Grade 3, 4, 5 TEAEs, serious adverse events (SAEs); deaths due to TEAEs and all deaths. |
| Registry ID | NCT07664735 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:38.379Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07664735
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.